by Scott Larrivee | Apr 16, 2025 | Podcast
On this episode, hosts Scott Larrivee and Sarah Scouten are joined by Matt Furlow, Associate Principal & Head of the Radiopharmaceutical Center of Excellence at ZS, about the evolving role of radiopharmaceuticals in oncology. With a PhD in bioengineering...
by Scott Larrivee | Feb 25, 2025 | News
WEST VALLEY CITY, Utah – Feb. 25, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced company management will present at the B. Riley Precision Oncology & Radiopharma Conference on Friday, Feb. 28, 2025 in New York City....
by Scott Larrivee | Jan 22, 2025 | News
Premier episode available today across all podcast platforms VALENCIA, Calif. – Jan. 22, 2025 – Nusano, a physics company transforming the production of radioisotopes, and Caspian Studios, an award-winning content-as-a-service studio, today announced the launch of the...
by Scott Larrivee | Jun 7, 2024 | News
VALENCIA, Calif. – June 7, 2024 – Nusano, Inc., a physics company transforming the production of medical radioisotopes, today announced industry veteran D. Scott Holbrook as chairman of its board. Holbrook is the co-founder of Invivo Molecular Imaging, and currently...
by Scott Larrivee | Aug 22, 2023 | News
With many now expecting radiopharmaceuticals to grow into a $20-30 billion market, investors are increasingly looking at the obstacles and opportunities for suppliers and drugmakers in this space. To advance these discussions, on Friday, May 12, 2023, Nusano and...
